Volume | 469 849 |
|
|||||
Actualités | - | ||||||
Maximum Haut | 1,6366 | Bas Haut |
|||||
Minimum Bas | 1,53 |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
Milestone Pharmaceuticals Inc | MIST | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
1,60 | 1,53 | 1,6366 | 1,54 | 1,58 |
Transactions Totales | Volume échangé | VWAP | Volume Financier | Volume en moyenne | Sur 52 semaines |
---|---|---|---|---|---|
923 | 469 849 | US$ 1,56 | US$ 734 379 | - | 1,33 - 4,44 |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
01:55:09 | formt | 130 | US$ 1,58 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
51,56M | 33,48M | - | 1M | -59,69M | -1,78 | - |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités Action Milestone Pharmaceuticals
Date | Heure | Source | Titre |
---|---|---|---|
04/3/2024 | 15:00 | Edgar (US Regulatory) | Form 8-K - Current report |
01/3/2024 | 22:52 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
29/2/2024 | 13:00 | GlobeNewswire Inc. | Milestone Pharmaceuticals Announces Pricing of $30.0 Million.. |
28/2/2024 | 22:37 | GlobeNewswire Inc. | Milestone Pharmaceuticals Announces Proposed Public Offering.. |
26/2/2024 | 13:06 | Edgar (US Regulatory) | Form 8-K - Current report |
15/2/2024 | 02:56 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
14/2/2024 | 13:10 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
26/12/2023 | 14:54 | Dow Jones News | Milestone Pharmaceuticals Shares Sink 24% After Receiving.. |
26/12/2023 | 13:57 | Dow Jones News | Milestone Pharmaceuticals' Etripamil Nasal Spray Application.. |
26/12/2023 | 13:15 | Edgar (US Regulatory) | Form 8-K - Current report |
21/11/2023 | 13:00 | PR Newswire (US) | Milestone Pharmaceuticals to Present at the Piper Sandler.. |
13/11/2023 | 13:05 | Edgar (US Regulatory) | Form 8-K - Current report |
Forum Action Milestone Pharmaceuticals
Aucune Discussion TrouvéeAjouter une Discussion
Historiques Milestone Pharmaceuticals Inc
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 1,65 | 1,72 | 1,50 | 1,62 | 90 936 | -0,07 | -4,24% |
1 mois | 1,78 | 1,87 | 1,50 | 1,72 | 144 334 | -0,20 | -11,24% |
3 mois | 1,68 | 2,40 | 1,36 | 1,73 | 333 607 | -0,10 | -5,95% |
6 mois | 2,45 | 3,52 | 1,33 | 1,95 | 303 682 | -0,87 | -35,51% |
1 an | 3,78 | 4,44 | 1,33 | 2,28 | 202 081 | -2,20 | -58,20% |
3 ans | 5,83 | 9,8465 | 1,33 | 4,54 | 182 950 | -4,25 | -72,90% |
5 ans | 15,61 | 27,73 | 1,33 | 6,50 | 493 919 | -14,03 | -89,88% |